Functional regulation of TEL by p38-induced phosphorylation

Biochemical and Biophysical Research Communications

Volumn 299, Issue 1, 2002, Pages 116-125

  Arai, Honoka ^a   Maki, Kazuhiro ^a   Waga, Kazuo ^a   Sasaki, Ko ^a   Nakamura, Yuichi ^a   Imai, Yoichi ^b   Kurokawa, Mineo ^b   Hirai, Hisamaru ^b   Mitani, Kinuko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

JNK; Leukemia; MAP kinase; p38; Stress signal; TEL; Transcription factor; Translocation; Tumor suppressor

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR ETV6; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; BLOTTING, WESTERN; COS CELLS; DNA-BINDING PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMANS; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLASMIDS; PRECIPITIN TESTS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; SERINE; SIGNAL TRANSDUCTION;

EID: 0036433402     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02588-3     Document Type: Article

References (67)

1. T.R. Golub, G.F. Barker, M. Lovett, D.G. Gilliland, Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation, Cell 77 (1994) 307-316.
2. H. Poirel, C. Oury, C. Carron, E. Duprez, Y. Laabi, A. Tsapis, S.P. Romana, M. Mauchauffe, M. Le Coniat, R. Berger, J. Ghysdael, O.A. Bernard, The TEL gene products: Nuclear phosphoproteins with DNA binding properties, Oncogene 14 (1997) 349-357.
3. R.G. Lopez, C. Carron, C. Oury, P. Gardellin, O. Bernard, J. Ghysdael, TEL is a sequence-specific transcriptional repressor, J. Biol. Chem. 274 (1999) 30132-30138.
4. C.A. Kim, M.L. Phillips, W. Kim, M. Gingery, H.H. Tran, M.A. Robinson, S. Faham, J.U. Bowie, Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression, EMBO J. 20 (2001) 4173-4182.
5. B.A. Kwiatkowski, L.S. Bastian, T.R. Bauer Jr., S. Tsai, A.G. Zielinska-Kwiatkowska, D.D. Hickstein, The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity, J. Biol. Chem. 273 (1998) 17525-17530.
6. M.D. Potter, A. Buijs, B. Kreider, L. van Rompaey, G. Grosveld, Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6, Blood 95 (2000) 3341-3348.
7. X. Gu, B.-H. Shin, Y. Akbarali, A. Weiss, J. Boltax, P. Oettgen, T.A. Libermann, Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6, J. Biol. Chem. 276 (2001) 9421-9436.
8. L. Wang, S.W. Hiebert, TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3, Oncogene 20 (2001) 3716-3725.
9. R. Martinez, T.R. Golub, Transcriptional repression of ID1 by the leukemogenic ETS protein TEL, Blood 96 (2000) 453a.
10. R. Fenrick, L. Wang, J. Nip, J.M. Amann, R.J. Rooney, J. Walker-Daniels, H.C. Crawford, D.L. Hulboy, M.S. Kinch, L.M. Matrisian, S.W. Hiebert, TEL, a putative tumor suppressor, modulates cell growth and cell morphology of Ras-transformed cells while repressing the transcription of stromelysin-1, Mol. Cell. Biol. 20 (2000) 5828-5839.
11. C. Jousset, C. Carron, A. Boureux, C.T. Quang, C. Oury, I. Dusanter-Fourt, M. Charon, J. Levin, O. Bernard, J. Ghysdael, A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein, EMBO J. 16 (1997) 69-82.
12. T.R. Golub, A. Goga, G.F. Barker, D.E. Afar, J. McLaughlin, S.K. Bohlander, J.D. Rowley, O.N. Witte, D.G. Gilliland, Oligomerization of the ABL tyrosine kinase by the Ets protein, Mol. Cell. Biol. 16 (1996) 4107-4116.
13. V. Lacronique, A. Boureux, V.D. Valle, H. Poirel, C.T. Quang, M. Mauchauffe, C. Berthou, M. Lessard, R. Berger, J. Ghysdael, O.A. Bernard, A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia, Science 278 (1997) 1309-1312.
14. Y. Kuno, A. Abe, N. Emi, M. Iida, T. Yokozawa, M. Towatari, M. Tanimoto, H. Saito, Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12), Blood 97 (2001) 1050-1055.
15. S.W. Hiebert, W. Sun, J.N. Davis, T. Golub, S. Shurtleff, A. Buijs, J. Downing, G. Grosveld, M.F. Roussel, D.G. Gilliland, N. Lenny, S. Meyers, The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription, Mol. Cell. Biol. 16 (1996) 1349-1355.
16. R. Fenrick, J.M. Amann, B. Lutterbach, L. Wang, J.J. Westendorf, J.R. Downing, S.W. Hiebert, Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein, Mol. Cell. Biol. 19 (1999) 6566-6574.
17. F. Guidez, K. Petrie, A.M. Ford, H. Lu, C.A. Bennett, A. MacGregor, J. Hannemann, Y. Ito, J. Ghysdael, M. Greaves, L.M. Wiedemann, A. Zelent, Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein, Blood 96 (2000) 2557-2561.
18. A. Buijs, L. van Rompaey, A.C. Molijn, J.N. Davis, A.C.O. Vertegaal, M.D. Potter, C. Adams, S. van Baal, E.C. Zwarthoff, M.F. Roussel, G.C. Grosveld, The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity, Mol. Cell. Biol. 20 (2000) 9281-9293.
19. L.C. Wang, F. Kuo, Y. Fujiwara, D.G. Gilliland, T.R. Golub, S.H. Orkin, Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL, EMBO J. 16 (1997) 4374-4383.
20. L.C. Wang, W. Swat, Y. Fujiwara, L. Davidson, J. Visvader, F. Kuo, F.W. Alt, D.G. Gilliland, T.R. Golub, S.H. Orkin, The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow, Genes Dev. 12 (1998) 2392-2402.
21. L. Chang, M. Karin, Mammalian MAP kinase signalling cascades, Nature 410 (2001) 37-40.
22. T. Obata, G.E. Brown, M.B. Yaffe, MAP kinase pathways activated by stress: The p38 MAPK pathway, Crit. Care Med. 28 (2000) N67-N77.
23. K. Ono, J. Han, The p38 signal transduction pathway: Activation and function, Cell. Signal. 12 (2000) 1-13.
24. R.J. Davis, Signal transduction by the JNK group of MAP kinases, Cell 103 (2000) 239-252.
25. Y. Takebe, M. Seiki, J. Fujisawa, P. Hoy, K. Yokota, K. Arai, M. Yoshida, N. Arai, SR α promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat, Mol. Cell. Biol. 8 (1988) 466-472.
26. T. Moriguchi, N. Kuroyanagi, K. Yamaguchi, Y. Gotoh, K. Irie, T. Kano, K. Shirakabe, Y. Muro, H. Shibuya, K. Matsumoto, E. Nishida, M. Hagiwara, A novel kinase cascade mediated by mitogen-activated protein kinase 6 and MMK3, J. Biol. Chem. 271 (1996) 13675-13679.
27. B. Derijard, M. Hibi, I.H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, R.J. Davis, JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain, Cell 76 (1994) 1025-1037.
28. R. Bosselut, J.F. Duvall, A. Gegonne, M. Bailly, A. Hemar, J. Brady, J. Ghysdael, The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1, EMBO J. 9 (1990) 3137-3144.
29. T. Tanaka, K. Mitani, M. Kurokawa, S. Ogawa, K. Tanaka, J. Nishida, Y. Yazaki, Y. Shibata, H. Hirai, Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias, Mol. Cell. Biol. 15 (1995) 2383-2392.
30. K. Maki, K. Mitani, T. Yamagata, M. Kurokawa, Y. Kanda, Y. Yazaki, H. Hirai, Transcriptional inhibition of p53 by MLL/MEN chimeric protein found in myeloid leukemia, Blood 93 (1999) 3216-3224.
31. E. Harlow, D. Lane, in: Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1988, pp. 421-510.
32. M. Kurokawa, K. Mitani, T. Yamagata, T. Tanaka, K. Izutsu, S. Ogawa, T. Moriguchi, E. Nishida, Y. Yazaki, H. Hirai, The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death, EMBO J. 19 (2000) 2958-2968.
33. K. Tobe, T. Kadowaki, H. Teramoto, K. Ueki, K. Hara, O. Koshio, K. Momomura, Y. Gotoh, E. Nishida, Y. Akamura, Y. Yamazaki, M. Kasuga, Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues, J. Biol. Chem. 266 (1991) 24793-24803.
34. J.T. Cheng, M.H. Cobb, R. Baer, Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1, Mol. Cell. Biol. 13 (1993) 801-808.
35. K. Okazaki, N. Sagata, The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH3T3 cells, EMBO J. 14 (1995) 5048-5059.
36. B.J. Pulverer, J.M. Kyriakis, J. Avruch, E. Nikolakaki, J.R. Woodgett, Phosphorylation of c-Jun mediated by MAP kinases, Nature 353 (1991) 670-674.
37. M. Towatari, G.E. May, R. Marais, G.R. Perkins, C.J. Marshall, S. Cowley, T. Enver, Regulation of GATA-2 phosphorylation by mitogen-activated protein kinase and interleukin-3, J. Biol. Chem. 270 (1995) 4101-4107.
38. T. Tanaka, M. Kurokawa, K. Ueki, K. Tanaka, Y. Imai, K. Mitani, K. Okazaki, N. Sagata, Y. Yazaki, Y. Shibata, T. Kadowaki, H. Hirai, The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability, Mol. Cell. Biol. 16 (1996) 3967-3979.
39. P. Young, P. McDonnell, D. Dunnington, A. Hand, J. Laydon, J. Lee, Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level, Agents Actions 39 (1993) C67-C69.
40. C.M. Slupsky, L.N. Gentile, L.W. Donaldson, C.D. Mackereth, J.J. Seidel, B.J. Graves, L.P. McIntosh, Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site, Proc. Natl. Acad. Sci. USA 95 (1998) 12129-12134.
41. B. Rabault, M.F. Roussel, C.T. Quang, J. Ghysdael, Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis, Oncogene 13 (1996) 877-881.
42. B.-S. Yang, C.A. Hauser, G. Henkel, M.S. Colman, C. van Beveren, K.J. Stacey, D.A. Hume, R.A. Maki, M.C. Ostrowski, Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2, Mol. Cell. Biol. 16 (1996) 538-547.
43. L.R. Bernstein, D.K. Ferris, N.H. Colburn, M.E. Sobel, A family of mitogen-activated protein kinase-related proteins interacts in vivo with activator protein-1 transcription factor, J. Biol. Chem. 269 (1994) 9401-9404.
44. V.N. Rao, E.S. Reddy, Elk-1 proteins interact with MAP kinases, Oncogene 9 (1994) 1855-1860.
45. T. Kallunki, B. Su, I. Tsigelny, H.K. Sluss, B. Derijard, G. Moore, R. Davis, M. Karin, JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation, Genes Dev. 8 (1994) 2996-3007.
46. S.-H. Yang, A. Galanis, A.D. Sharrocks, Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors, Mol. Cell. Biol. 19 (1999) 4028-4038.
47. R. Janknecht, W.H. Ernst, V. Pingoud, A. Nordheim, Activation of ternary complex factor Elk-1 by MAP kinases, EMBO J. 12 (1993) 5097-5104.
48. R. Marais, J. Wynne, R. Treisman, The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain, Cell 73 (1993) 381-393.
49. H. Gille, M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M.H. Cobb, P.E. Shaw, ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation, EMBO J. 14 (1995) 951-962.
50. R. Janknecht, W.H. Ernst, A. Nordheim, SAP1a is a nuclear target of signaling cascades involving ERKs, Oncogene 10 (1995) 1209-1216.
51. T. Strahl, H. Gille, P.E. Shaw, Selective response of ternary complex factor Sap1a to different mitogen-activated protein kinase sub-groups, Proc. Natl. Acad. Sci. USA 93 (1996) 11563-11568.
52. M.A. Price, A.E. Rogers, R. Treisman, Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET), EMBO J. 14 (1995) 2589-2601.
53. M.A. Price, F.H. Cruzalegui, R. Treisman, The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light, EMBO J. 23 (1996) 6552-6563.
54. A. Brunet, A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, M.J. Anderson, K.C. Arden, J. Blenis, M.E. Greenberg, Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor, Cell 96 (1999) 857-868.
55. G.J.P.L. Kops, N.D. de Ruiter, A.M.M. De Vries-Smits, D.R. Powell, J.L. Bos, B.M.T. Burgering, Direct control of the forkhead transcription factor AFX by protein kinase B, Nature 398 (1999) 630-634.
56. J. Nakae, B.C. Park, D. Accili, Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway, J. Biol. Chem. 274 (1999) 15982-15985.
57. G. Rena, S.D. Guo, S.C. Cichy, T.G. Unterman, P. Cohen, Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B, J. Biol. Chem. 274 (1999) 17179-17183.
58. H. Takaishi, H. Konishi, H. Matsuzaki, Y. Ono, Y. Shirai, N. Saito, T. Kitamura, W. Ogawa, M. Kasuga, U. Kikkawa, Y. Nishizuka, Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B, Proc. Natl. Acad. Sci. USA 96 (1999) 11836-11841.
59. E.D. Tang, G. Nunez, F.G. Barr, K.L. Guan, Negative regulation of the forkhead transcription factor FKHR by Akt, J. Biol. Chem. 274 (1999) 16741-16746.
60. G. Rena, Y.L. Woods, A.R. Prescott, M. Peggie, T.G. Unterman, M.R. Williams, P. Cohen, Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion, EMBO J. 21 (2002) 2263-2271.
61. S. Guo, G. Rena, S. Cichy, X. He, P. Cohen, T. Unterman, Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence, J. Biol. Chem. 274 (1999) 17184-17192.
62. A.M. Brownawell, G.J. Kops, I.G. Macara, B.M. Burgering, Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the transcription factor AFX, Mol. Cell. Biol. 21 (2001) 3534-3546.
63. G. Rena, A.R. Prescott, S.D. Guo, P. Cohen, T.G. Unterman, Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting, Biochem. J. 354 (2001) 605-612.
64. J. Park, N.R. Yaseen, P.G. Hogan, A. Rao, S. Sharma, Phosphorylation of the transcription factor NFATp inhibits its DNA binding activity in cyclosporin A-treated human B and T cells, J. Biol. Chem. 270 (1995) 20653-20659.
65. D.N. Sgouras, M.A. Athanasiou, G.J. Beal Jr., R.J. Fisher, D.G. Blair, G.J. Mavrothalassitis, ERF: An ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation, EMBO J. 14 (1995) 4781-4793.
66. L. Le Gallic, D. Sgouras, G. Beal Jr., G. Mavrothalassitis, Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation, Mol. Cell. Biol. 19 (1999) 4121-4133.
67. L. van Rompaey, M. Potter, C. Adams, G. Grosveld, Tel induces a G1 arrest and suppresses Ras-induced transformation, Oncogene 19 (2000) 5244-5250.